Exchange: NYSEMkt·Updated 05:12 PM EDT
PTN logo

PTN Palatin Technologies Inc.

$13.08
$0.24
(1.87%)
Today
Closed $13.08
$0.00
(0.00%)
After Hours
Reported EarningsMay 13
Mkt Cap$22.85M
Vol534,543.00

About PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.
61

Bullish Sentiment

How do you feel about PTN?

Advertisement|Remove ads.